Summary of Significant Accounting Policies (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Sales Returns and Allowances
Allowance for customer returns	$ 85,000	$ 70,000
Receivables
Note receivable	81,634
Note receivable, additional disclosure	The predecessor company disposed of a dormant product line of vitamins in December 2010. As part of the consideration in this divestiture, the Company received from the purchaser of this product line an unsecured note in the amount of $170,000. The original note was due to be repaid on or before March 2014, where interest accrued principally at an annual rate of 5%, based upon the initial $170,000 principal and was payable monthly. As of March 31, 2013, the note was novated and a new promissory note was issued to reflect a modification in the payment terms, which includes no interest.
Note receivable, maturity date	May 01, 2017
Property and Equipment
Depreciation expense	65,774	83,450
Intangible Assets
Amortization expense	12,800	11,698
Revenue Recognition
Revenue recognition, returns, allowances and discounts	2,656,122	2,114,060
Leases
Leases, future payments	547,290
Marketing
Marketing, deferred advertising costs	0	7,651
Marketing, expense	1,500,362	2,232,548
Research and Development Expense
Research and development costs	99,676	162,297
Headquarters Lease
Leases
Leases, rent expense	82,863	82,863
Leases, expiration date	Jan. 31, 2017
Leases, future payments	172,632
Warehouse Lease
Leases
Leases, rent expense	0
Leases, expiration date	Dec. 31, 2018
Leases, future payments	$ 374,658
Minimum
Intangible Assets
Estimated useful lives	3 years
Maximum
Intangible Assets
Estimated useful lives	10 years